Login
Navigate Fool.com
Will STML beat
the market?
Community Rating: 2 Stars: Unattractive

16.68 0.70 (4.38%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.13
Previous Close $15.98
Daily Range $15.72 - $17.19
52-Week Range $11.75 - $47.25
Market Cap $220.2M
P/E Ratio -6.80
Dividend (Yield) $0.00 (0.0%)
Volume 285,599
Average Daily Volume 206,008
Current FY EPS -$2.06

How do you think STML
will perform against the market?

Top STML Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Where are They Now? Biotech IPO Class of 2013, March Edition

A look at what Stemline, KalaBios, and Tetraphase have accomplished in their first year as public companies.

3 Biggest Winners in Biotech Last Week

What were the biggest movers in biotech last week?

3 Humongous Health-Care Stocks This Week

Therapeutics ruled the world of health-care this week -- with Chelsea, PTC, and Stemline coming out on top and Sarepta and Cell not far behind.

A Year-End Look at 3 High-Flying Biotech IPOs of 2013: PETX, RCPT, STML

Aratana Therapeutics Inc., Receptos Inc., and Stemline Therapeutics Inc. are three biotech IPOs of 2013 that are finishing the year with strong gains. Can they continue soaring into 2014?

3 Stocks Near 52-Week Highs Worth Selling

Are these three stocks sells or belles? You be the judge!

See More STML News...

Sector

Industry

STEMLINE THERAPEUTICS INC COM USD0.0001 (STML) Description

STEMLINE THERAPEUTICS INC COM USD0.0001 Website: http://www.stemline.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks